Apitope International NV

Where the EU money came from

Funding by EU programme. Amounts are Apitope International NV's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Apitope International NV led 1 of them as coordinator. Each links to the official record.

• RTCurePartner

  Rheuma Tolerance for Cure

  Horizon 2020 · 2017–2023 · Project on CORDIS ↗

  €169ktheir share
• DAVIADCoordinator

  The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  €3.5Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Karolinska InstitutetSweden · 1 shared project
• King'S College LondonUnited Kingdom · 1 shared project
• The University of BirminghamUnited Kingdom · 1 shared project
• Academisch Ziekenhuis LeidenNetherlands · 1 shared project
• University of GlasgowUnited Kingdom · 1 shared project
• University of Newcastle Upon TyneUnited Kingdom · 1 shared project
• Medizinische Universitaet WienAustria · 1 shared project
• Universitatsklinikum ErlangenGermany · 1 shared project
• Fondazione Per L'Istituto di Ricerca In BiomedicinaSwitzerland · 1 shared project
• Semmelweis EgyetemHungary · 1 shared project
• Glaxosmithkline Biologicals SABelgium · 1 shared project
• Janssen Pharmaceutica NVBelgium · 1 shared project
• Deutsches Rheuma ForschungszentrumberlinGermany · 1 shared project
• The University of QueenslandAustralia · 1 shared project
• Sanofi-Aventis Deutschland GmbHGermany · 1 shared project
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• autoimmune diseases
• biomolecules
• rheumatology
• vaccines